Evanthia Nikolopoulou

Evanthia Nikolopoulou has a strong background in scientific research, with experience in various roles at different organizations. Evanthia is currently working at Quell Therapeutics as a Senior Scientist, starting in April 2021. Prior to that, they were a Senior Scientist at Adaptimmune from February 2019 to March 2021.

Evanthia also has experience at the University College London, where they worked as a Senior Post-Doctoral Research Associate from January 2013 to February 2019. In this role, they managed scientific projects, mentored and collaborated on research programs, and was responsible for laboratory management and organization of scientific meetings. Evanthia also designed student projects and developed research grant applications, showcasing their creative problem-solving skills and extensive experimental experience.

Before their time at University College London, Evanthia was a PhD Candidate at Imperial College London from September 2008 to September 2012. Their research during this period focused on identifying molecular signaling pathways triggered by arachidonic acid, resulting in the publication of a first-author paper and contributions to collaborative scientific projects.

Overall, Evanthia Nikolopoulou has a diverse range of experience in scientific research and has made significant contributions in various roles throughout their career.

Evanthia Nikolopoulou attended the Ethnikon kai Kapodistriakon Panepistimion Athinon from 2001 to 2006, where they obtained a Bachelor of Science (BSc) degree in the field of University of Athens. Later, they pursued further education at Imperial College London, completing a Master of Science (MSc) degree in Reproductive and Developmental Biology from 2006 to 2007. Evanthia continued their studies at Imperial College London, where they obtained a Doctor of Philosophy (PhD) degree in Molecular Biology from 2008 to 2012.